Literature DB >> 33414515

The war against pancreatic cancer in 2020 - advances on all fronts.

Tejeshwar Jain1, Vikas Dudeja2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33414515     DOI： 10.1038/s41575-020-00410-4

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  12 in total

1.  A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.

Authors:  Chunle Zhao; Jun Gong; Yu Bai; Taoyuan Yin; Min Zhou; Shutao Pan; Yuhui Liu; Yang Gao; Zhenxiong Zhang; Yongkang Shi; Feng Zhu; Hang Zhang; Min Wang; Renyi Qin
Journal:  Cell Death Differ       Date:  2022-07-29       Impact factor: 12.067

2.  Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma.

Authors:  Yunzhen Qian; Yitao Gong; Xuan Zou; Yu Liu; Yusheng Chen; Ruijie Wang; Zhengjie Dai; Yesiboli Tasiheng; Xuan Lin; Xu Wang; Guopei Luo; Xianjun Yu; He Cheng; Chen Liu
Journal:  Oncogenesis       Date:  2022-06-24       Impact factor: 6.524

3.  siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.

Authors:  Jae Yun Jung; Hyun Jin Ryu; Seung-Hwan Lee; Dong-Young Kim; Myung Ji Kim; Eun Ji Lee; Yeon-Mi Ryu; Sang-Yeob Kim; Kyu-Pyo Kim; Eun Young Choi; Hyung Jun Ahn; Suhwan Chang
Journal:  Cells       Date:  2021-10-13       Impact factor: 6.600

Review 4.  Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination.

Authors:  Zeyu Wang; Shasha Zhao; Xiaolin Lin; Guanglong Chen; Jiawei Kang; Zhongping Ma; Yiming Wang; Zhi Li; Xiuying Xiao; Aina He; Dongxi Xiang
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

5.  Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma.

Authors:  Fei-Ting Hsu; Chang Liang Tsai; I-Tsang Chiang; Keng-Hsueh Lan; Po-Fu Yueh; Wen-Yi Liang; Chi-Shuo Lin; Yee Chao; Keng-Li Lan
Journal:  J Cell Mol Med       Date:  2022-02-17       Impact factor: 5.310

6.  Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells.

Authors:  Aleyda Benitez-Amaro; Neus Martínez-Bosch; Noemí Manero-Rupérez; Lene Claudi; Maria Teresa La Chica Lhoëst; Marta Soler; Lia Ros-Blanco; Pilar Navarro; Vicenta Llorente-Cortés
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 7.  Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.

Authors:  Alain Couvineau; Thierry Voisin; Pascal Nicole; Valerie Gratio; Anne Blais
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

8.  Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.

Authors:  Lang Jia; Yun Zhang; Feng Pu; Chong Yang; Shula Yang; Jinze Yu; Zihan Xu; Hongji Yang; Yu Zhou; Shikai Zhu
Journal:  Aging (Albany NY)       Date:  2022-02-27       Impact factor: 5.682

9.  Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.

Authors:  Hao Yuan; Jinhui Liu; Li Zhao; Pengfei Wu; Guosheng Chen; Qun Chen; Peng Shen; Taoyue Yang; Shaoqing Fan; Bin Xiao; Kuirong Jiang
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

Review 10.  Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting.

Authors:  Utpreksha Vaish; Tejeshwar Jain; Abhi C Are; Vikas Dudeja
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.